Literature DB >> 6854431

Projections of asbestos-related disease 1980-2009.

A M Walker, J E Loughlin, E R Friedlander, K J Rothman, N A Dreyer.   

Abstract

Approximately 19,000 cases of mesothelioma and 55,000 cases of lung cancer will arise in U.S. men with histories of nontrivial occupational exposure to asbestos. There are approximately 65,000 U.S. men now alive with clinically diagnosable asbestosis. These estimates are based, in the case of the cancer, on estimates of the effective number of asbestos-exposed workers required to produce the current national incidence of mesothelioma. The asbestosis estimates are based on a number of rough measures relating the prevalence of asbestosis to the incidence of mesothelioma, the incidence of compensable asbestosis in other countries, the prevalence of and mortality from pneumoconioses generally, and the number of workers heavily exposed to asbestos.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854431

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  14 in total

1.  Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma.

Authors:  Prasad S Adusumilli; Mei-Ki Chan; Yun Shin Chun; Michael Hezel; Ting-Chao Chou; Valerie W Rusch; Yuman Fong
Journal:  Cancer Biol Ther       Date:  2006-01-12       Impact factor: 4.742

2.  Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers.

Authors:  G Berry
Journal:  Br J Ind Med       Date:  1991-12

3.  The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey.

Authors:  Serdar Berk; Huseyin Yalcin; Omer Tamer Dogan; Kursat Epozturk; Ibrahim Akkurt; Zehra Seyfikli
Journal:  Environ Geochem Health       Date:  2013-04-04       Impact factor: 4.609

4.  A methodology for identifying workers exposed to asbestos since 1940.

Authors:  M Stanbury; K D Rosenman
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

5.  Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

Authors:  D J Sugarbaker; J P Garcia; W G Richards; D H Harpole; E Healy-Baldini; M M DeCamp; S J Mentzer; M J Liptay; G M Strauss; S J Swanson
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

6.  Projection of asbestos related diseases in the United States, 1985-2009. I. Cancer.

Authors:  D E Lilienfeld; J S Mandel; P Coin; L M Schuman
Journal:  Br J Ind Med       Date:  1988-05

Review 7.  Radiation associated malignant pleural mesothelioma.

Authors:  Y Lerman; Y Learman; P Schachter; E Herceg; Y Lieberman; A Yellin
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

8.  Malignant mesothelioma: attributable risk of asbestos exposure.

Authors:  R Spirtas; E F Heineman; L Bernstein; G W Beebe; R J Keehn; A Stark; B L Harlow; J Benichou
Journal:  Occup Environ Med       Date:  1994-12       Impact factor: 4.402

9.  Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.

Authors:  Prasad S Adusumilli; Brendon M Stiles; Mei-Ki Chan; Michael Mullerad; David P Eisenberg; Leah Ben-Porat; Rumana Huq; Valerie W Rusch; Yuman Fong
Journal:  J Gene Med       Date:  2006-05       Impact factor: 4.565

10.  Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.

Authors:  Kaitlyn J Kelly; Yanghee Woo; Peter Brader; Zhenkun Yu; Christopher Riedl; Shu-Fu Lin; Nanhai Chen; Yong A Yu; Valerie W Rusch; Aladar A Szalay; Yuman Fong
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.